| Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults (NCT05219617) | SK Life Science, Inc. | 2022-04-28 |
| Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies (NCT05364021) | Longboard Pharmaceuticals | 2022-03-03 |
| Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution (NCT05044819) | Jazz Pharmaceuticals | 2021-07-07 |
| Investigation of Cognitive Outcomes With Cannabidiol Oral Solution (NCT04133480) | Jazz Pharmaceuticals | 2020-10-01 |
| Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome (NCT04611438) | Yonsei University | 2020-03-30 |
| Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome (NCT04062981) | SK Life Science, Inc. | 2019-05-03 |
| A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome (NCT03936777) | Zogenix, Inc. | 2019-04-22 |
| Long-term Cardiac Monitoring in Epilepsy (NCT03955432) | Northwell Health | 2019-03-19 |
| Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome (NCT03731715) | SK Life Science, Inc. | 2019-02-07 |
| A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies (NCT03650452) | Takeda | 2018-08-08 |
| Turmeric as Treatment in Epilepsy (NCT03254680) | NYU Langone Health | 2018-03-01 |
| A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol (NCT03467113) | Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | 2018-01-19 |
| Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome (NCT02318537) | INSYS Therapeutics Inc | 2017-12-30 |
| A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome (NCT03355209) | Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | 2017-11-27 |
| The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy (NCT02815540) | Gillette Children's Specialty Healthcare | 2017-02-16 |
| Trial to Assess Vagus Nerve Stimulation Therapy in Children With Lennox-Gastaut Syndrome (NCT02632149) | Beijing Pins Medical Co., Ltd | 2016-10-01 |
| The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy (NCT02910297) | Gillette Children's Specialty Healthcare | 2016-09-01 |
| Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy (NCT02655198) | KU Leuven | 2016-01-01 |
| An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes (NCT02224573) | GW Research Ltd | 2015-06-11 |
| Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults (NCT02224560) | Jazz Pharmaceuticals | 2015-06-08 |
| A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults (NCT02224690) | Jazz Pharmaceuticals | 2015-04-28 |
| Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome (NCT02175173) | Eisai Co., Ltd. | 2013-06-13 |
| Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects (NCT01370486) | Institution de Lavigny | 2011-08-01 |
| A Long Term Extension Study of E2080 in Lennox-Gastaut Patients (NCT01151540) | Eisai Co., Ltd. | 2010-11-01 |
| Transcranial Direct Current Stimulation, Treatment of Childhood Drug-Resistant Lennox-Gastaut Syndrome, A Pilot Study (NCT02731300) | Khon Kaen University | 2010-08-01 |
| A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304) (NCT01146951) | Eisai Limited | 2010-06-01 |
| European Registry of Anti-Epileptic Drug Use in Patients With Lennox-Gastaut Syndrome (LGS) (NCT01991041) | Eisai Limited | 2008-06-01 |
| Epilepsy Phenome/Genome Project (NCT00552045) | University of California, San Francisco | 2007-11-01 |
| Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome (NCT01160770) | Lundbeck LLC | 2005-12-01 |
| Ketogenic Diet for Child Epilepsy and Seizure Control (NCT00004729) | National Institute of Neurological Disorders and Stroke (NINDS) | 1997-07-01 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome (NCT00004776) | National Center for Research Resources (NCRR) | 1993-11-01 |
| An Extended Access Program (EAP) for Participants Who Have Completed Rufinamide Study E2080-G000-303 (NCT03778424) | Eisai Inc. | |
| An Extended Access Program (EAP) for Perampanel (NCT02307578) | Eisai Inc. | |